New approach to treating multiple sclerosis

October 14, 2018 12:02 am | Updated 02:12 pm IST

Researchers have identified an enzyme that triggers autoimmune responses from T cells in patients with multiple sclerosis (MS). These immune cells also reacted to a bacterial variant of the enzyme, supporting the idea that molecular “mimics” from members of the microbiome could be a driving factor in MS — an autoimmune condition that affects around 2.5 million people worldwide. MS arises when the immune system attacks the protective coating that sheathes neurons and transmits electrical impulses in the brain and spinal cord, resulting in a wide range of neurological issues. Although the disorder’s origins are masked by a complex array of genetic and environmental risk factors, scientists have theorised that many MS cases could be triggered by molecules from pathogens or bacterial microbiota. The researchers report preparing a T cell clone, previously isolated from MS brain lesions, and found the clone reacted against an enzyme named GDP-L-fucose synthase. The authors then examined CD4+ T cells from the cerebrospinal fluid (CSF) of 31 MS patients, and discovered nearly 40% of the individuals also displayed reactivity to the enzyme. The findings appear in Science Translational Medicine .

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.